Paper Details

Paper Title

Donanemab (LY3002813) Phase 1b Study in Alzheimer's Disease: Rapid and Sustained Reduction of Brain Amyloid Measured by Florbetapir F18 Imaging.

Paper Journal Title

J Prev Alzheimers Dis

Paper Citation Count

Paper Publication Year

2021

Bio Mention

Mesh Descriptor

Column Actions